Related Experiment Video
Updated: Jun 13, 2026
08:48
Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis
Ping Shi1, Yanming Wei, Jiayu Zhang
1Graduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KY, USA.
Journal of Alzheimer'S Disease : JAD
|May 14, 2010
Summary
Mitochondrial dysfunction is a key factor in amyotrophic lateral sclerosis (ALS) pathogenesis. Impaired mitochondria, especially in axons, contribute to this fatal neurodegenerative disease, highlighting their importance for therapy development.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease requiring better therapeutic strategies.
- ALS is considered a multifactorial and multisystem disorder with various proposed pathological mechanisms.
- Mitochondria are implicated as an early target in ALS pathogenesis and disease progression.
Purpose of the Study:
- To review the role of mitochondrial dysfunction in ALS.
- To explore how mutant SOD1 affects mitochondrial integrity and function.
- To discuss the implications of mitochondrial defects in axonal transport and neuromuscular junctions.
Main Methods:
- Review of existing literature on ALS pathogenesis.
- Analysis of studies on mitochondrial morphology and function in ALS patients and models.
- Examination of evidence linking mutant SOD1 to mitochondrial impairment.
- Investigation of disrupted axonal transport of mitochondria.
Main Results:
- Mitochondrial defects are observed early in ALS, both in patients and in mouse models with mutant SOD1.
- Mutant SOD1 directly associates with mitochondria, leading to impaired function.
- Axonal transport of mitochondria is disrupted in ALS.
- Mitochondrial dynamics (fission/fusion) and mitophagy may be affected by mutant SOD1.
Conclusions:
- Mitochondrial dysfunction is a central converging point for multiple pathways in ALS.
- Maintaining mitochondrial function in axons and neuromuscular junctions is crucial for ALS.
- These findings support the
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...